Infertility: Clinical Trials

101 trials for Infertility, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

53 completed, 23 unknown, 8 recruiting, 6 terminated. 101 Phase 1, 37 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1101Completed 53, Unknown 23, Recruiting 8, Terminated 6, Withdrawn 5, Active not recruiting 3, Suspended 2, Not yet recruiting 1
Phase 237Completed 16, Unknown 12, Recruiting 4, Active not recruiting 2, Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Infertility: new trials by email Literature Review of Infertility trials Research Report on Infertility

Trials (filtered) newest first · largest first

All 101 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility
human umbilical cord mesenchymal stem cell complex collagen, intrauterine injection - Infertility, Female
Phase 1SuspendedSclnow Biotechnology Co., Ltd.242026-12-312026-04-23
Opt-IVF for Personalized Medicine for Normal Responders
Opt-IVF, control - Ivf
Phase 1 / Phase 2Active not recruitingUrmila DIwekar1002026-10-152026-11-03
Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI
Drospirenone drug, Cetrorelix 0.25 mg - Poor Ovarian Reserve, Infertility (IVF Patients)
Phase 1 / Phase 2Not yet recruitingAhmed Saad1002026-08-012026-07-30
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia
Leflutrozole, Dose 2 - Infertility Due to Azoospermia, Infertility, Male
Phase 1 / Phase 2Active not recruitingMartin Blomberg Jensen152026-04-212026-10-21
An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin
Desogestrel and ethinylestradiol fixed dose combination, Follitropin alfa/lutropin alfa - Fertility
Phase 1CompletedMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany242025-11-242026-03-18
An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera
Opt-IVF, Control - Infertility (IVF Patients)
Phase 1 / Phase 2RecruitingUrmila DIwekar2002025-09-232025-09-29
A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump
Lutrepulse - Amenorrhea, Fertility
Phase 1WithdrawnFerring Pharmaceuticals2025-09-122025-11-14
A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants
Test: Follitropin alfa, Reference: Follitropin alfa, Zoladex - Hypogonadism
Phase 1CompletedEMD Serono Research & Development Institute, Inc.552025-07-212026-02-24
A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects
STSP-0902 injection, Placebo - Oligozoospermia
Phase 1RecruitingStaidson (Beijing) Biopharmaceuticals Co., Ltd642025-05-082026-05-22
Effect of NAE on Polycystic Ovarian Syndrome (PCOS)
Herbal Formulation, Metformin XR, Metformin 750 mg and herbal formulation 500 mg - Polycystic Ovarian Syndrome (PCOS), Infertility
Phase 1CompletedJinnah Sindh Medical University1162025-04-102026-06-22
Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers
QL1012D, Gonal-F® - Infertility, Female
Phase 1Active not recruitingQilu Pharmaceutical Co., Ltd.482025-04-062026-02-17
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia
AlloRx - Testicular Injury, Oligospermia
Phase 1WithdrawnThe Foundation for Orthopaedics and Regenerative Medicine2025-04-032025-04-06
A Study of HS-10518 in Healthy Adult Premenopausal Females in China
HS-10518, Placebo - Infertility, Female
Phase 1CompletedWest China Second University Hospital602025-03-112026-03-25
NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia
Denosumab (Prolia), Letrozole (Aromatase Inhibitors) - Infertility, Male
Phase 1 / Phase 2CompletedMartin Blomberg Jensen162025-03-012026-10-21
Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome
Herbal Formulation, Metformin XR, Metformin 750 mg and herbal formulation 500 mg - Polycystic Ovarian Syndrome (PCOS), Herbal Medicine
Phase 1CompletedJinnah Postgraduate Medical Centre1162025-02-222026-06-23
Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study
Mechanically Engineered Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes, Umbilical cord mesenchymal stem cell-derived exosomes, platelet-rich plasma - Thin Endometrial Lining, Female Infertility
Phase 1 / Phase 2RecruitingTang-Du Hospital902025-02-212025-03-26
Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg®
Medicinal product MediReg® (Human Mesenchymal Stromal Cell Secretome), lyophilizate for preparation of solution for injection in patients with severe spermatogenesis disorders, Clostilbegit (clomiphene) 50 mg 1 tablet x 1 p a day - 3 months, Triovit - 1 tablet x 1 p a day - 3 months, Folic acid - 1 tablet x 1 p a day - 3 months. - Azoospermia, Nonobstructive, Teratospermia
Phase 1 / Phase 2RecruitingLomonosov Moscow State University Medical Research and Educational Center802024-11-262025-03-11
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
Follicle Stimulating Hormone - Infertility, Obesity
Phase 1RecruitingUniversity of Colorado, Denver602024-10-012026-10-14
Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.
Gonadotropins Subcutaneous - Ovarian Stimulation, Infertility
Phase 1CompletedIBSA Institut Biochimique SA282024-09-232026-07-16
Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA
Gonadotropins Subcutaneos - OVARIAN STIMULATION, Infertility
Phase 1CompletedIBSA Institut Biochimique SA292024-09-152026-01-26

Showing 20 of 101. Sign in to see all of them.

Narrower conditions

Infertility, Female (29)  ·  Infertility, Male (11)  ·  Polycystic Ovary Syndrome (7)  ·  Oligospermia (4)  ·  Aneuploidy (3)  ·  Azoospermia (3)  ·  Primary Ovarian Insufficiency (3)  ·  Anxiety Disorders (2)  ·  Depression (2)  ·  Endometriosis (2)  ·  Gynatresia (2)  ·  Insulin Resistance (2)  ·  Metabolic Diseases (2)  ·  Amenorrhea (1)

Broader conditions

Genital Diseases (101)  ·  Urogenital Diseases (101)  ·  Female Urogenital Diseases (37)  ·  Female Urogenital Diseases and Pregnancy Complications (37)  ·  Genital Diseases, Female (37)  ·  Genital Diseases, Male (16)  ·  Male Urogenital Diseases (16)  ·  Endocrine System Diseases (10)  ·  Gonadal Disorders (10)  ·  Adnexal Diseases (9)  ·  Ovarian Diseases (9)  ·  Cysts (7)  ·  Neoplasms (7)  ·  Ovarian Cysts (7)

Interventions

Sodium Chloride (5)  ·  follitropin alfa (5)  ·  Progesterone (4)  ·  Clomiphene (3)  ·  Ethinyl Estradiol (3)  ·  Filgrastim (3)  ·  Metformin (3)  ·  Acupuncture Therapy (2)  ·  Denosumab (2)  ·  Embryo Transfer (2)  ·  Estradiol (2)  ·  Glycoprotein Hormones, alpha Subunit (2)  ·  Gonadotropin-Releasing Hormone (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Injections (2)

Sponsors

Ain Shams University (4)  ·  Ferring Pharmaceuticals (4)  ·  ART Fertility Clinics LLC (3)  ·  Al-Azhar University (3)  ·  Hadassah Medical Organization (3)  ·  IBSA Institut Biochimique SA (3)  ·  Martin Blomberg Jensen (3)  ·  Royan Institute (3)  ·  Universitair Ziekenhuis Brussel (3)  ·  Alphamab Jilin Co., Ltd. (2)  ·  Center for Human Reproduction (2)  ·  Glycotope GmbH (2)  ·  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (2)  ·  National and Kapodistrian University of Athens (2)  ·  Sclnow Biotechnology Co., Ltd. (2)

Countries

China (20)  ·  United States (20)  ·  Egypt (11)  ·  Iran (5)  ·  Canada (4)  ·  Denmark (4)  ·  Israel (4)  ·  Belgium (3)  ·  United Arab Emirates (3)  ·  Greece (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Pakistan (2)  ·  Russia (2)  ·  Spain (2)

Top investigators

Barbara Lawrenz, PhD (2)  ·  David H Barad, MD, MS (2)  ·  Norbert Gleicher, MD (2)  ·  Sayed Bakry, PhD (2)  ·  Yoel Shufaro, MD PhD (2)  ·  Abd-Elnasr M Ali, MD (1)  ·  Ahmed Abbas, MD (1)  ·  Ahmed Fata, MD (1)  ·  Ahmed Kadeh, MSc (1)  ·  Ahmed S Saad, MD (1)  ·  Aimee Eyvazzadeh, MD, MS, MBA (1)  ·  Anastasia Efimenko, doctor of sciences (1)

Results publications

PMID 28591833, PMID 22459631, PMID 24406076, PMID 24424357, PMID 25398971, PMID 26303743, PMID 26664408, PMID 28508691, PMID 29375477, PMID 29486615, PMID 30796792, PMID 31029557, PMID 31616379, PMID 31710189, PMID 31900292, PMID 32181337, PMID 32195207, PMID 32720198, PMID 32898291, PMID 34532462, PMID 34711824, PMID 35137345, PMID 36089055, PMID 36273309, PMID 36369425, PMID 36478528, PMID 36537742, PMID 37013570, PMID 38588501, PMID 39152484, PMID 39165278, PMID 39280787, PMID 39643206, PMID 42457811

NIH funding

2023 (2), 2014 (1), 2025 (1), P50HD104224 (1)